Sleep apnea, a common yet underdiagnosed sleep disorder, contributes to the development of dementia among adults — particularly women, a Michigan Medicine study suggests. At every age level, women with known or suspected sleep apnea were more likely than men to be diagnosed with dementia.
Lifesaving cancer therapies can cause serious side effects, both immediately and later in life. "It is essential to continue to study innovative approaches that will eradicate the disease but won't diminish the quality of life for patients diagnosed with cancer," says Roberto Leon-Ferre, M.D., a breast medical oncologist at Mayo Clinic. With breast cancer rates rising among younger people, the need for treatments that provide excellent outcomes with fewer side effects is only increasing.
Increasing ketones in the blood through a keto diet or supplements may help put irregular menstrual cycles back on schedule or even restart a period that appears to have stalled for good, new research suggests.
Dr. Sedrak, who directs the Cancer and Aging Program at the UCLA Health Jonsson Comprehensive Cancer Center(Link opens in new window), discusses what inspired his work, the challenges cancer survivors face as they age, and the exciting advancements in cancer and aging research that could reshape patient care in the years to come.
Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way that ovarian cancer tumors manipulate their environment to resist immunotherapy and identified a drug target that could overcome that resistance. The study, published in the October 30 online issue of Cell used a cutting-edge spatial genomics technology and preclinical animal models, with tumor specimens from ovarian cancer patients further validating the findings. They found that ovarian cancer cells produce a molecule called Interleukin-4 (IL-4), which is typically associated with asthma and the skin condition eczema, also known as atopic dermatitis. The study went on to find that the cancer cells used IL-4 to create a protective environment that kept away killer immune cells, making the tumors resistant to immunotherapy. A drug, dupilumab, which blocks IL-4’s activity, has been approved by the Food and Drug Administration (FDA) and is already used to treat asthma and eczema. This new study suggests dupi
An international team of imaging, engineering and cancer experts is developing a novel mobile breast cancer diagnostic kit to improve early diagnosis in low- and middle-income countries — such as Uganda, where systemic delays lead to an advanced stage diagnosis in 70% of breast cancer cases.  
University Hospitals’ community health investment totaled $707 million last year, including investments in maternal and child health, addressing food insecurity, creating jobs for under-resourced individuals and continuing to provide charity care to the uninsured.
Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to assess which patients with metastatic triple-negative breast cancer could benefit from immunotherapy.
Last June, the Supreme Court dismissed a case that would have determined whether emergency abortion care is protected under a federal law known as the Emergency Medical Treatment and Labor Act or... ...
A new study led by Yale Cancer Center researchers at Yale School of Medicine titled, "Living Flat: Stories from Women of Color After Mastectomy," explains how cultural factors, spirituality, and personal beliefs play an important role in the lives of women of color after mastectomies.
A recent analysis reveals that the number of chronic kidney disease (CKD) cases in women around the globe nearly tripled in the past three decades. Also, type 2 diabetes and hypertension were the leading causes of CKD-related deaths in women. The research will be presented at ASN Kidney Week 2024 October 23– 27.
Transforming breast cancer treatment and prevention, a breast-cancer survivor and doctoral candidate focuses her research on adolescent and young adult cancer disparities, research on tracking glioblastoma progression and more are included in this month's tip sheet.
This week the Biden Administration proposed a new rule that would expand access to birth control, including making over the counter birth control pills free for women of reproductive age who have... ...
New study in JNCCN-Journal of the National Comprehensive Cancer Network that finds that people diagnosed with an aggressive breast cancer subtype (HR-negative, HER2-positive) are more likely to live longer in states that participate in Medicaid expansion under the Affordable Care Act (ACA).
Breast cancer takes a major toll on Caribbean women. They are often diagnosed at a younger age than women in the U.S., and have one of the highest mortality rates worldwide. A new study in JAMA Network Open suggests that these higher rates may be linked to shifting patterns in reproductive health.
Researchers are developing an objective, quantitative score for pain by measuring over 30 biomarkers including stress hormones, inflammation markers and neurotransmitters, as well as other physiological responses, The aim is to eliminate variation and bias in the treatment of chronic pain in women.
The Uniformed Services University of the Health Sciences (USU) is part of a team, led by Tufts University, along with Northwestern Medicine, that has been selected by the Advanced Research Projects Agency for Health (ARPA-H) as an awardee of the Sprint for Women’s Health.
University Hospitals has been approved for $9.2 million in research funding by the Patient-Centered Outcomes Research Institute (PCORI). The study is led by David Sheyn, MD, division director of urogynecology and pelvic reconstructive surgery at University Hospitals Urology Institute, and aims to study bulking versus sling for treating urinary incontinence at the time of vaginal prolapse repair.
Cedars-Sinai and UCLA investigators studied first trimester placental tissue and found that for some genes, the process that turns their information into a biological function may depend on the sex of the fetus.
The American Society of Human Genetics (ASHG) Annual Meeting will bring together the largest gathering of human geneticists in the world in Denver, Colorado on November 5-9.